CBS and neoplasm: High intratumoral CBS levels have been influenced by the accumulation of mutations in tumor suppressor genes (such as APC, SMAD4, and TP53) and in oncogenes (such as KRAS), as well as by tumor metabolism, invasion, metastasis, and increased resistance to chemotherapy [70].